Membrane vesicles mediate pro-angiogenic activity of equine adipose-derived mesenchymal stromal cells.
Authors: Pascucci Luisa, Alessandri Giulio, Dall'Aglio Cecilia, Mercati Francesca, Coliolo Paola, Bazzucchi Cinzia, Dante Sara, Petrini Stefano, Curina Giovanni, Ceccarelli Piero
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary Equine adipose-derived mesenchymal stromal cells (E-AdMSCs) are recognised for their regenerative potential, but their therapeutic mechanisms extend beyond direct cellular activity to include paracrine signalling via membrane vesicles (MVs)—specifically exosomes and shedding vesicles. Pascucci and colleagues investigated whether E-AdMSCs produce bioactive MVs capable of promoting angiogenesis, using electron microscopy to visualise vesicle production and rat aortic ring and scratch assays to assess their pro-angiogenic effects. The research confirmed that E-AdMSCs constitutively release MVs that stimulate endothelial cell activity and blood vessel formation, demonstrating genuine intercellular communication rather than passive bystander activity. For equine practitioners administering MSC-based therapies—whether for tendon, ligament, or soft tissue injuries—these findings suggest that the therapeutic benefit may depend not solely on cell survival and differentiation, but significantly on the secreted vesicle cargo; this distinction has implications for optimising treatment protocols and potentially for developing acellular vesicle-based therapeutics as a more practical alternative to live cell transplantation. Further research characterising MV composition, stability, and delivery mechanisms will be essential before vesicle therapy becomes a standardised clinical tool, but this work establishes a compelling biological rationale for pursuing this approach in equine regenerative medicine.
Read the full abstract on PubMed
Practical Takeaways
- •Adipose-derived stem cell therapies may work through membrane vesicle signalling rather than cell presence alone, potentially allowing development of cell-free therapeutic products for regenerative applications
- •Understanding that MSC benefits come from secreted vesicles suggests future treatments could use isolated vesicles rather than live cells, improving storage, transport, and standardisation for clinical use
- •This foundational work supports further investigation of stem cell-derived vesicles as therapeutic tools for equine tissue repair, particularly in conditions requiring new blood vessel formation
Key Findings
- •Equine adipose-derived mesenchymal stromal cells constitutively produce membrane vesicles (exosomes and shedding vesicles)
- •Membrane vesicles from E-AdMSCs stimulate angiogenesis in rat aortic ring and scratch assays
- •Membrane vesicles mediate intercellular communication between MSCs and endothelial cells
- •Membrane vesicles represent a key paracrine mechanism of MSC therapeutic effects in tissue regeneration